Susan Kelliher - Chemours President
| CC Stock | USD 21.94 0.41 1.90% |
President
Ms. Susan M. Kelliher is Senior Vice President Human Resources and Health Services of the company. Ms. Kelliher joined Chemours in 2017 from Albemarle Corporation, where she served as Senior Vice President Human Resources for the global specialty chemical company. Prior to Albemarle, she served as Vice President Human Resources at Hewlett Packard, where she held a number of leadership positions on global teams including Imaging and Printing and Global Sales and Enterprise Marketing from 2007 to 2012. Before joining Hewlett Packard, Ms. Kelliher served as Vice President Human Resources for Cymer, Inc., where she led the people function. She joined Cymer from The Home Depot where, from 2004 to 2007, she was the Vice President Human Resources for the growth engines of the company Business Development and Home Services including responsibility for due diligence and integration for the companys acquisitions. From 2000 to 2004, Ms. Kelliher served as Senior Director of Human Resources for Corporationrationrate Business Development and International Operations for the Raytheon Company . Prior to Raytheon, she served as the Director of Human Resources Western Region for YUM Brands, Pizza Hut division from 1995 to 2000. Ms. Kelliher started her career at Mobil Oil, where her career progressed through a variety of assignments including support for new ventures in Europe, Russia, and Africa from 1990 to 1995. since 2017.
| Age | 57 |
| Tenure | 7 years |
| Address | 1007 Market Street, Wilmington, DE, United States, 19801 |
| Phone | 302 773 1000 |
| Web | https://www.chemours.com |
Chemours Management Efficiency
The company has Return on Asset (ROA) of 0.0397 % which means that for every $100 of assets, it generated a profit of $0.0397. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.1102 %, which means that it produced $0.1102 on every 100 dollars invested by current stockholders. Chemours' management efficiency ratios could be used to measure how well Chemours manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.03. The current year's Return On Capital Employed is expected to grow to -0.02. At present, Chemours' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 703.5 M, whereas Total Assets are forecasted to decline to about 7.5 B.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Aaron Erter | Sherwin Williams Co | 45 | |
| Benjiman Corona | Kronos Worldwide | 63 | |
| Michael Crocco | Air Products and | 58 | |
| Amy Samford | Kronos Worldwide | 50 | |
| Richard Roudeix | LyondellBasell Industries NV | 57 | |
| Thomas Gilligan | Sherwin Williams Co | 63 | |
| Darrell Brown | Ecolab Inc | 60 | |
| Bryan Hanley | Kronos Worldwide | 43 | |
| Mary Garceau | Sherwin Williams Co | 51 | |
| Michael Simmons | Kronos Worldwide | 52 | |
| Rebecca Liebert | PPG Industries | 53 | |
| Wolfgang Brand | Air Products and | N/A | |
| Clarence Brown | Kronos Worldwide | 51 | |
| Kristin McCoy | Kronos Worldwide | 48 | |
| Dale Friedrichs | LyondellBasell Industries NV | 60 | |
| Todd Slater | Olin Corporation | 60 | |
| Joshua Bagshaw | Sherwin Williams Co | 43 | |
| Courtney Riley | Kronos Worldwide | 58 | |
| Jonathan Reid | Sherwin Williams Co | 52 | |
| James Brown | Kronos Worldwide | 63 | |
| Brian Gallagher | Sherwin Williams Co | 52 | |
Management Performance
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0397 |
Chemours Leadership Team
Elected by the shareholders, the Chemours' board of directors comprises two types of representatives: Chemours inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chemours. The board's role is to monitor Chemours' management team and ensure that shareholders' interests are well served. Chemours' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chemours' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dawn Farrell, Independent Chairman of the Board | ||
| Curtis Anastasio, Independent Director | ||
| Jonathan Lock, Senior Vice President and Chief Development Officer | ||
| Amber Wellman, Chief Officer | ||
| Matthew Abbott, Vice President - Digital and Analytics Platforms Leader | ||
| Shane Hostetter, Senior CFO | ||
| David Shelton, Senior Vice President, General Counsel, Secretary | ||
| Denise Dignam, President - Advanced Performance Materials | ||
| Curtis Crawford, Independent Director | ||
| Aditya Beri, Interim Business | ||
| Mary Cranston, Independent Director | ||
| Bradley Bell, Independent Director | ||
| Sheryl Telford, Chief Sustainability Officer | ||
| Ron Charles, Senior People | ||
| Erin Kane, Independent Director | ||
| Alisha Bellezza, President - Thermal & Specialized Solutions | ||
| Joseph Martinko, President Solutions | ||
| Susan Kelliher, Senior Vice President – Human Resources and Health Services | ||
| Gerardo Calderon, President Materials | ||
| Eugene Snell, President - Titanium Technologies | ||
| Sandra Rogers, Independent Director | ||
| Kurt Bonner, Ma Relations | ||
| Kristine Wellman, General VP | ||
| Sean Keohane, Independent Director | ||
| Sameer Ralhan, Chief Financial Officer, Senior Vice President, Treasurer | ||
| Shane CPA, Senior CFO | ||
| Guillaume Pepy, Independent Director | ||
| Brandon Ontjes, Vice Relations | ||
| Camela Wisel, Chief Accounting Officer, Vice President Controller | ||
| Mark Newman, Chief Operating Officer, Senior Vice President | ||
| Edwin Sparks, President - Chemical Solutions Business, Titanium Technologies | ||
| Erich Parker, Senior Vice President of Corporate Communications and Chief Brand Officer. | ||
| Brian Shay, Interim Officer | ||
| Mark Vergnano, President, Chief Executive Officer, Director | ||
| Richard Brown, Independent Chairman of the Board | ||
| Alvenia Scarborough, Senior Vice President - Corporate Communications and Chief Brand Officer |
Chemours Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Chemours a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0397 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 6.91 B | ||||
| Shares Outstanding | 149.41 M | ||||
| Shares Owned By Insiders | 0.72 % | ||||
| Shares Owned By Institutions | 82.90 % | ||||
| Number Of Shares Shorted | 7.7 M | ||||
| Price To Earning | 25.49 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Diversified Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.65) | Dividend Share 1 | Earnings Share 0.5 | Revenue Per Share 38.519 | Quarterly Revenue Growth 0.009 |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.